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Supplemental Figure 1.  DDK isolated from egg extracts can phosphorylate Claspin in vitro. 
Interphase egg extracts were immunoprecipitated with either anti-Drf1 or control antibodies.  The 
immunoprecipitates were added to in vitro kinase reactions containing bacterially-expressed GST-Mcm2 
(lanes 6 and 7), His6-Claspin-FLAG (lanes 3 and 4), or no recombinant protein (lanes 1 and 2) in the 
presence of [γ-32P]ATP.  The reaction in lane 5 contains His6-Claspin-FLAG and [γ-32P]ATP but no 
immunoprecipitated samples.  The reactions were subjected to SDS-PAGE, stained with Coomassie 
Brilliant Blue (CBB) (top panel), and analyzed by autoradiography (bottom panel).  Kinase assays were 
carried out as described (33). 
 
Supplemental Figure 2.  Loading controls for Figure 2A and B. 
(A) Aliquots of extracts (2%) containing recombinant proteins from Figure 2A (lanes 2-17) were taken 
prior to immunoprecipitation.  Lane 1 is an aliquot of extract with no recombinant proteins.  Samples 
were immunoblotted with Drf1 and GST. 
(B) Aliquots of extracts (2%) of extracts with the recombinant proteins from Figure 2B (lanes 1-8) were 
taken prior to immunoprecipitation.  Lane 9 is an aliquot of extract with no recombinant proteins.  
Samples were immunoblotted for Claspin and GST. 
 
Supplemental Figure 3.  Additional structure-function studies of the DDK-Claspin interaction. 
Interphase, nuclei-free egg extracts containing GST-Claspin(847-903), GST-Claspin(847-877), GST-
Claspin(878-903), GST-Claspin(902-961), GST-Claspin(776-851), or no recombinant protein (lanes 2 
and 3) were immunoprecipitated with anti-Drf1 (D) or mock (M) control antibodies and immunoblotted 
for Drf1 and GST.  Lanes 1, 4, 7, 10, 13, and 16 are aliquots (2%) of extracts containing recombinant 
proteins taken before immunoprecipitation, and lane 19 is an aliquot of the initial extract.   
 
Supplemental Figure 4.  Characterization of point mutations in the DDK-interacting region of Claspin. 
(A) Interphase, nuclei-free egg extracts containing wild-type GST-Claspin(856-867), GST-Claspin(856-
867)-Q866K, GST-Claspin(856-867)-D861E, GST-Claspin(856-67)-E/K, and GST were 
immunoprecipitated with anti-Drf1 antibodies (lanes 7-11).  Extract containing wild-type GST-
Claspin(856-867) was also mock immunoprecipitated with control antibodies (lane 12).  Lane 1 contains 
an aliquot of pre-IP interphase extract prior to immunoprecipitation, and lanes 2-6 contain 2% of pre-IP 
extracts supplemented with the recombinant proteins listed above.  The immunoprecipitates were 
immunoblotted for Drf1 and GST. 
(B) Interphase, nuclei-free egg extracts containing wild-type GST-Claspin(776-1078), GST-Claspin(776-
1078)-Q866K, GST-Claspin(776-1078)-D861E, GST-Claspin(776-1078)-E/K, and GST were 
immunoprecipitated with anti-Drf1 antibodies (lanes 7-11).  Extract containing wild-type GST-
Claspin(776-1078) was also mock immunoprecipitated with control antibodies (lane 12).  Lane 1 contains 
an aliquot of pre-IP interphase extract, and lanes 2-6 contain 2% of pre-IP extracts supplemented with the 
recombinant proteins listed above.  The immunoprecipitates were immunoblotted for Drf1 and GST. 
 
Supplemental Figure 5.  Loading control for Figure 4C. 
Aliquots of extracts (2%) with the recombinant proteins from Figure 4C (lanes 1-7) were taken prior to 
immunoprecipitation.  Lanes 8 and 9 are aliquots of extract with no recombinant proteins.  Samples were 
immunoblotted for Claspin and GST. 
 
Supplemental Figure 6.  Concentration of recombinant Claspin proteins for Figure 6. 
Undepleted (lane 1), Claspin-depleted (lane 2) and mock-depleted egg extracts (lane 3) were 
supplemented with buffer alone (lanes 4 and 8) or either wild-type His6-Claspin-FLAG (lane 5) or the 
indicated mutant proteins (lanes 6 and 7).  Extracts were assayed for DNA replication (lanes 4-8) as 
described in Figure 6.  Samples were immunoblotted for Claspin and Orc2.  Immunoblots depict the 
results from one representative immunodepletion and reconstitution experiment from Figure 6. 
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